In a recent publication in Biomaterials, a multidisciplinary team from Radboudumc (Dentistry; theme Reconstructive and regenerative medicine), Radboud University (Molecular Materials), and the Association of Dutch Burn Centres present their first results with a recently developed thermogel for use in wound repair.Changing wound dressings inflicts pain and may disrupt wound repair. Novel synthetic thermosensitive hydrogels based on polyisocyanopeptide (PIC) offer a solution. These gels are liquid below 16 °C and form gels beyond room temperature. The architecture and mechanical properties of PIC gels closely resemble collagen and fibrin, including the characteristic stiffening response at high strains. In a full-thickness dorsal skin wound model in mice wounds were treated with PIC gel and PIC-RGD gel for 3 and 7 days and analyzed. The absence of adverse effects, ease of application, and the possibilities for bio-functionalization make the biomimetic PIC hydrogels suitable for development into wound dressings. Since we aim to bring this material to the patient setting, we closely collaborate with the Dutch burns foundation and Dutch burn centres. We hope to soon present additional data that further demonstrate the usefulness of this novel thermogel.
Publication:Op 't Veld RC, van den Boomen OI, Lundvig DMS, Bronkhorst EM, Kouwer PHJ, Jansen JA, Middelkoop E, Von den Hoff JW, Rowan AE, Wagener FADTG* Thermosensitive biomimetic polyisocyanopeptide hydrogels may facilitate wound repair. Biomaterials.
Related news items
650,000 Euro funding for research into the phasing out of medication for leukaemia patients30 July 2020
With a 650,000 euro funding from ZonMw, researchers from the Haematology and Pharmacy departments can develop a medication phasing out strategy for patients with chronic myeloid leukaemia. This strategy will be tested in practice.read more
Increased role of patients after bowel cancer treatment30 July 2020
Approximately 14,000 patients get colorectal cancer every year. Almost all patients are operated on and monitored afterwards (follow-up). In 2019 Radboudumc started a new approach to follow-up research after the treatment of stage II/III colorectal cancer.read more
ERC Proof of Concept grant received by Ronald van Rij30 July 2020
Ronald van Rij, theme Infectious diseases and global health, received an ERC (European Research Council) Proof of Concept grant of 150,000 euros, in order to make arbovirus vaccines even safer.read more
Hypatia fellowship Call is open30 July 2020
The Hypatia fellowship round with the deadline 31 May has been canceled. Therefore, the next available deadline will be 27 September 2020. Radboudumc researchers are invited to scout young potentials to fill the strategic gaps within the research themes imbedded in RIHS and RIMLS.read more
Mihai Netea and colleagues published two papers back-to-back in The Journal of Clinical Investigation.29 July 2020
These back-to-back articles investigated the effect of BCG vaccination on trained immunity. The first article shows that BCG vaccination inhibits systemic inflammation, depending on gender. The second article demonstrates that the circadian rhythm influences the induction of trained immunity.read more
Genetic mutation reveals how coronavirus strikes TLR7 plays essential role in disease process28 July 2020
''Does a congenital immune defect play an important role in the defense against Coronavirus?'' This was published by Cas van der Made, Frank van der Veerdonk and Alexander Hoischen.read more